Francesco Muntoni,Barry J. Byrne,Hugh J. McMillan,Monique M. Ryan,Brenda L. Wong,Juergen Dukart,Amita Bansal,Valerie Cosson,Roxana Dreghici,Maitea Guridi,Michael Rabbia,Hannah Staunton,Giridhar S. Tirucherai,Karl Yen,Xiling Yuan,Kathryn R. Wagner,Irvith Carvajal,Anjaneya Chimalakonda,Jochem Gokemeijer,Michael Gulianello,Nicole Hellbach,Alexander Kozhich,Daniel Kukral,Harold Malone,Jere E. Meredith,Mathew Pletcher,Ginger Rakestraw,Lumelle Schneeweis,Joanna Swain,Frank Zambito,Ming Chang,Lora Hamuro,Feng Luo,Jon E. Peterson,Peter Hocknell,Zhen Lou,Malavi Madireddi,Mathew Pletcher,Clifford M. Bechtold,Michael K. Ahlijanian,Ming Chang,Lora Hamuro,Leslie K. Jacobsen,Alexander Kozhich,Feng Luo,Jon E. Peterson,Frank Zambito,Heidemarie Kletzl,Alberto L. Dubrovsky,Lilia Mesa,Fernando Chloca,Agustin Jauregu,Kristi Jones,Monique Ryan,Craig Campbell,Jean Mah,Alice Ho,Angela Chiu,Vanessa D’Souza,Raymy Sadowski,Julie Dao,Michaela Grice,Tiffany Price,Hugh McMillan,Erick Sell,Anna McCormick,Teresa Gidaro,Andrea Seferian,Yann Péréon,Armelle Magot,Carole Vuillerot,Ulrike Schara-Schmidt,Valerie Sansone,Emilio Albamonte,Alessandra Di Bari,Jasmine Refran,Francesca Salmin,Giuseppe Vita,Gian Luca Vita,Chiara Consulo,Hirofumi Komaki,Akihiko Ishiyama,Tsuyoshi Matsumura,Toshio Saito,Kana Ichihara,Naoki Hayashi,Kouji Terada,Kenji Takehara,Nobuko Hayashi,Yasuhiro Takeshima,Andres Nascimiento,Daniel Natera,Laura Carrera,Jesica Exposito,Carlos Ortez,Julita Medina,Obdulia Moya,Sandra Roca,Alicia Rodriguez,Maria Valle,Imelda J. M. de Groot,Erik H. Niks,Marjolein J. van Heur-Neuman,Menno van der Holst,Mariacristina Scoto,Chiara Brusa,Abidha Afazal,Eveline Miller,Barry J. Byrne,Linda Cripe,Richard S. Finkel,Peter Heydemann,Katherine Matthews,Chandra Miller,Katie Laubsher,Shelley Mockeler,Han Phan,Kumaraswamy Sivakumar,Kristy Osgood,Jeffrey Statland,Cuixia Tian,Kathryn R. Wagner,Doris Leung,Genila Bibat,Nikia Stinson,Laurent Servais,Eugenio Mercuri,Tina Duong,Mariacristina Scoto,Craig Campbell,Paul Strijbos,Klaas Veenstra,the Taldefgrobep Alfa Study Group

Abstract:Duchenne muscular dystrophy (DMD) is a genetic muscle disorder that manifests during early childhood and is ultimately fatal. Recently approved treatments targeting the genetic cause of DMD are limited to specific subpopulations of patients, highlighting the need for therapies with wider applications. Pharmacologic inhibition of myostatin, an endogenous inhibitor of muscle growth produced almost exclusively in skeletal muscle, has been shown to increase muscle mass in several species, including humans. Taldefgrobep alfa is an anti-myostatin recombinant protein engineered to bind to and block myostatin signaling. Preclinical studies of taldefgrobep alfa demonstrated significant decreases in myostatin and increased lower limb volume in three animal species, including dystrophic mice.

Title : Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy

O.13 Interference of Myostatin and TGF-beta Signaling by Antisense-Mediated Exon Skipping in ALK4/5 Receptors

Exon-skipped dystrophins for treatment of Duchenne muscular dystrophy: mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics

Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties

Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor.

Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy

RNA-seq analysis, targeted long-read sequencing and in silico prediction to unravel pathogenic intronic events and complicated splicing abnormalities in dystrophinopathy

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Targeting TGF-|[beta]| Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-|[beta]| Type I Receptor

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy

Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle

Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy

A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy

Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies